news
More countries added to the EU-US mutual recognition agreement
Luxembourg and the Netherlands have been included in the mutual recognition agreement between the EU and the FDA in the US.
List view / Grid view
Drug Markets
news
Three more US states announce lawsuits against Purdue
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.
news
Global contraceptive pill market to grow 6.6 percent
The global contraceptive pill market is expected to increase to US$8.8 billion by 2024, report finds.
news
Pharmaceutical intermediates market to see growth
The global pharmaceutical intermediates market is likely to see year-on-year growth in 2019, by an estimated 3.6 percent rate.
news
New partnership established to track drugs using blockchain
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
news
More effective, safe drugs drive biobetter market growth
The global biobetters market is set to increase due to demand for higher efficacy and safer drugs.
news
US prescription drug costs soar but price transparency is lacking
A research team from Scripps Research Translational Institute has published revealing figures in relation to drug prices in the US.
news
Recommendations released to help the EU combat high drug prices
New briefing documents provide policy recommendations to help the EU tackle high medicines prices brought about by market monopolies.
news
Proposed biosimilar accepted for review by EMA
The EMA has accepted Prestige BioPharma’s marketing application for its trastuzumab biosimilar.
news
Shingles vaccine approved for use in China
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.
news
WHO announces support for drug pricing transparency
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
news
API markets to grow 6.8 percent by 2026
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
news
British Columbia first province to switch patients to biosimilars
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
news
CPhI China opens with analysis pointing to a surge in growth in 2019
Regulatory reforms and harmonisation reported as key drivers of industry in China.
news
Retail prices on several anti-cancer medications slashed
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
